Company Description
ImmunoGen is TAPping into cancer research. The firm's product candidates are TAPs, or tumor-activated prodrugs, that combine cancer-killing drugs...
Key ImmunoGen Financials
| Company Type | Public - NASDAQ (GM): IMGN Main Headquarters |
|---|---|
| Fiscal Year-End | June |
| 2008 Sales (mil.) | $40.3 |
| 2006 Employees | 192 |
More ImmunoGen Financials (11 pages)
Competition
Competitive Landscape for Chemicals
Demand is driven by the health of the US economy because chemicals are used to make a wide variety of industrial and consumer products. The profitability of individual companies is closely tied to...
Read more about ImmunoGen's competition across multiple industries
Top ImmunoGen Competitors
Sponsored Links
The Business Directory
ImmunoGen Executives
| Title | Name & Bio | Contact |
|---|---|---|
| Chairman | Mitchel (Mitch) Sayare | Network | E-mail |
| President, CEO, and Director | Daniel M. (Dan) Junius | Network | E-mail |
| Executive Director Investor Relations and Corporate Communications | Carol Hausner | Network | E-mail |
| Are You Listed On Hoover's? | ||
|---|---|---|
| Hoover's subscribers also get access to information on people who have self-listed with this company. Subscribers also have the option to add themselves to this company record. |
Tools from our advertising partners:
Current ImmunoGen News
- BioWorld Today December 10, 2008 [BioWorld Today] (10 Dec 2008 00:01:00 EST)
Sponsored Opportunity
